Clusterin has been shown to be upregulated in the spinal cord of patients with amyotrophic lateral sclerosis (ALS) and has been shown to protect against TDP‐43 protein misfolding in animal and cell models. This evidence concerns the gene CLU and amyotrophic lateral sclerosis.